PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.250
+0.110 (9.65%)
May 8, 2026, 4:00 PM EDT - Market closed
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $69.77 million as of May 8, 2026. Its market cap has increased by 16.43% in one year.
Market Cap
69.77M
Enterprise Value
59.98M
1-Year Change
16.43%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $69.77M, an increase of 53.30%. That is a compound annual growth rate of 6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 69.77M | 65.63% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 75.54M |
| PMV Pharmaceuticals | 75.19M |
| XBiotech | 75.00M |
| Seres Therapeutics | 74.17M |
| KALA BIO | 73.71M |
| ImmuCell | 72.83M |
| Atara Biotherapeutics | 70.99M |
| OS Therapies | 69.78M |